Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06123533
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-11-08
First Post:
2023-10-31
Brief Title:
Understanding Womens Values in Managing Human Papillomavirus HPV
Sponsor:
University of Aberdeen
Organization:
University of Aberdeen
Study Overview
Official Title:
An Exploratory Study to Understand Womens Values of Management of a Positive Human Papillomavirus HPV Test From the Cervical Screening Programme
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Almost all cervical cancers are caused by infection with a high-risk hr HPV In March 2020 the Scottish Cervical Screening programme changed from a test to look for abnormal cervical cells caused by hr-HPV to a test that looks for infection with hr-HPV itself If an HPV infection persists there is an increased risk of a pre-cancer or cancer of the cervix developing in the future The cervical screening programme aims to detect and treat pre-cancers so they dont progress to cancer of the cervix
Most HPV infections do not cause symptoms and will clear on their own There are no active treatments available currently Following a positive hr-HPV result by waiting and repeating the HPV test after 12 months it is known that 60 of infections clear in that year and more will clear each year after Some women are anxious when they find out that they have an HPV infection and some will look to see if there are any treatments available
Several private organisations are offering HPV treatments which are not approved for clinical use yet These may or may not help clear up HPV more quickly or more often
This study is designed to help us to know and understand whether women have considered treatments which benefits or risks of such treatments they value and which factors influence these decisions The study will also seek to determine participants willingness to pay for such treatments and will also help to facilitate discussions between clinicians and patients
Most HPV infections do not cause symptoms and will clear on their own There are no active treatments available currently Following a positive hr-HPV result by waiting and repeating the HPV test after 12 months it is known that 60 of infections clear in that year and more will clear each year after Some women are anxious when they find out that they have an HPV infection and some will look to see if there are any treatments available
Several private organisations are offering HPV treatments which are not approved for clinical use yet These may or may not help clear up HPV more quickly or more often
This study is designed to help us to know and understand whether women have considered treatments which benefits or risks of such treatments they value and which factors influence these decisions The study will also seek to determine participants willingness to pay for such treatments and will also help to facilitate discussions between clinicians and patients
Detailed Description:
A scoping review was conducted to determine the background information and evidence available with regards to treatment of persistent human papillomavirus HPV in women This scoping review which will become a systematic review evidenced that there was a knowledge gap on how to manage persistent HPV Several different treatment options were identified with some studies being conducted as randomised controlled trials and some being conducted as cohort studies
In March 2020 the Scottish Cervical Screening programme changed from cervical cytology test test of disease testing of cells taken by a brush from the cervix and analysed under a microscope to testing for high-risk HPV a test of risk If an HPV infection persists there is an increased risk of having precancer or cancer of the cervix in the future
Informing women that they have a viral infection which can result in cancer has in effect created a new disease as women would not have been aware of this infection Most HPV infections do not cause symptoms and there are no active treatments available in the NHS This has created concerns for some women who may want to find a treatment and feel that surveillance where 60 of infections should regress is doing nothing
Several private organisations are offering HPV treatments which are not available in the NHS and which may help clear up HPV including HPV vaccination and probiotics and vaginal gels This proposal will take steps towards understanding an unmet need among women who have high-risk HPV and who are on early repeat HPV testing It will seek to understand whether women have considered treatments which benefits or risks of such treatments are valued and which factors influence these decisions as a health economics study
Although these treatments require further evidence and development prior to being adopted as options for patient care conducting this research will provide valuable insights into what women value The profiles of the different treatments vary significantly and understanding patient preferences will help guide prioritisation Understanding initially how women feel about their HPV diagnosis and the available treatments will be important to design a pilot discrete choice experiment DCE and usable DCE to understand in quantitative terms what women seek prioritise and are willing to pay for in their care for HPV
This study is being performed to provide valuable insights to conduct a DCE The results of the participant interviews and the DCE will be highly useful to help inform policy guidelines and clinical recommendations for the management of women with persistent HPV
In March 2020 the Scottish Cervical Screening programme changed from cervical cytology test test of disease testing of cells taken by a brush from the cervix and analysed under a microscope to testing for high-risk HPV a test of risk If an HPV infection persists there is an increased risk of having precancer or cancer of the cervix in the future
Informing women that they have a viral infection which can result in cancer has in effect created a new disease as women would not have been aware of this infection Most HPV infections do not cause symptoms and there are no active treatments available in the NHS This has created concerns for some women who may want to find a treatment and feel that surveillance where 60 of infections should regress is doing nothing
Several private organisations are offering HPV treatments which are not available in the NHS and which may help clear up HPV including HPV vaccination and probiotics and vaginal gels This proposal will take steps towards understanding an unmet need among women who have high-risk HPV and who are on early repeat HPV testing It will seek to understand whether women have considered treatments which benefits or risks of such treatments are valued and which factors influence these decisions as a health economics study
Although these treatments require further evidence and development prior to being adopted as options for patient care conducting this research will provide valuable insights into what women value The profiles of the different treatments vary significantly and understanding patient preferences will help guide prioritisation Understanding initially how women feel about their HPV diagnosis and the available treatments will be important to design a pilot discrete choice experiment DCE and usable DCE to understand in quantitative terms what women seek prioritise and are willing to pay for in their care for HPV
This study is being performed to provide valuable insights to conduct a DCE The results of the participant interviews and the DCE will be highly useful to help inform policy guidelines and clinical recommendations for the management of women with persistent HPV
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None